Organization
Stephenson Cancer Center at the University of Oklahoma
2 abstracts
Abstract
Safety and efficacy of DB-1303 in patients with advanced/metastatic solid tumors: A multicenter, open-label, first-in-human, phase 1/2a study.Org: Stephenson Cancer Center at the University of Oklahoma, Macquarie University Cancer Institute, Phase I Clinical Trial Center, Fudan University Shanghai Cancer Center, Shanghai, China, Hunan Provincial People's Hospital, Changsha, China, Linyi Cancer Hospital,
Abstract
Evaluating root causes contributing to real-world disparities in ovarian cancer care: Insights from an implementation science initiative utilizing tethered patient-provider surveys and chart reviews.Org: PRIME Education LLC, Stephenson Cancer Center at the University of Oklahoma,